VCAM1 and Cognitive impairment: VCAM‐1 up‐regulation at the BBB is a crucial step in age‐related cognitive deficits, indicating VCAM‐1 as a potential therapeutic target for age‐related neurodegeneration.[236] Leukocytes bind to endothelial cells through integrin‐VCAM‐1 interaction.